Literature DB >> 16814732

Critical role of STAT3 in leptin's metabolic actions.

Christoph Buettner1, Alessandro Pocai, Evan D Muse, Anne M Etgen, Martin G Myers, Luciano Rossetti.   

Abstract

Leptin has pleiotropic effects on glucose homeostasis and feeding behavior. Here, we validate the use of a cell-permeable phosphopeptide that blocks STAT3 activation in vivo. The combination of this biochemical approach with stereotaxic surgical techniques allowed us to pinpoint the contribution of hypothalamic STAT3 to the acute effects of leptin on food intake and glucose homeostasis. Leptin's ability to acutely reduce food intake critically depends on intact STAT3 signaling. Likewise, hypothalamic signaling of leptin through STAT3 is required for the acute effects of leptin on liver glucose fluxes. Lifelong obliteration of STAT3 signaling via the leptin receptor in mice (s/s mice) results in severe hepatic insulin resistance that is comparable to that observed in db/db mice, devoid of leptin receptor signaling. Our results demonstrate that the activation of the hypothalamic STAT3 pathway is an absolute requirement for the effects of leptin on food intake and hepatic glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16814732      PMCID: PMC3638026          DOI: 10.1016/j.cmet.2006.04.014

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  59 in total

Review 1.  Obesity as a medical problem.

Authors:  P G Kopelman
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

2.  Overfeeding rapidly induces leptin and insulin resistance.

Authors:  J Wang; S Obici; K Morgan; N Barzilai; Z Feng; L Rossetti
Journal:  Diabetes       Date:  2001-12       Impact factor: 9.461

3.  Intracellular signalling. Key enzyme in leptin-induced anorexia.

Authors:  K D Niswender; G J Morton; W H Stearns; C J Rhodes; M G Myers; M W Schwartz
Journal:  Nature       Date:  2001-10-25       Impact factor: 49.962

Review 4.  Designing cell-permeant phosphopeptides to modulate intracellular signaling pathways.

Authors:  D J Dunican; P Doherty
Journal:  Biopolymers       Date:  2001       Impact factor: 2.505

5.  Physiological increase in plasma leptin markedly inhibits insulin secretion in vivo.

Authors:  J A Cases; I Gabriely; X H Ma; X M Yang; T Michaeli; N Fleischer; L Rossetti; N Barzilai
Journal:  Diabetes       Date:  2001-02       Impact factor: 9.461

6.  Nitric oxide mediates leptin-induced preovulatory luteinizing hormone and prolactin surges in rats.

Authors:  H Watanobe; H B Schiöth
Journal:  Brain Res       Date:  2001-12-27       Impact factor: 3.252

7.  Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation.

Authors:  J Turkson; D Ryan; J S Kim; Y Zhang; Z Chen; E Haura; A Laudano; S Sebti; A D Hamilton; R Jove
Journal:  J Biol Chem       Date:  2001-09-28       Impact factor: 5.157

Review 8.  Leptin.

Authors:  R S Ahima; J S Flier
Journal:  Annu Rev Physiol       Date:  2000       Impact factor: 19.318

9.  Selective deletion of leptin receptor in neurons leads to obesity.

Authors:  P Cohen; C Zhao; X Cai; J M Montez; S C Rohani; P Feinstein; P Mombaerts; J M Friedman
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

10.  Defective STAT signaling by the leptin receptor in diabetic mice.

Authors:  N Ghilardi; S Ziegler; A Wiestner; R Stoffel; M H Heim; R C Skoda
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

View more
  94 in total

Review 1.  [Adipokine update - new molecules, new functions].

Authors:  Carmen Gelsinger; Alexander Tschoner; Susanne Kaser; Christoph F Ebenbichler
Journal:  Wien Med Wochenschr       Date:  2010-08

2.  Disruption of hypothalamic leptin signaling in mice leads to early-onset obesity, but physiological adaptations in mature animals stabilize adiposity levels.

Authors:  Laurence E Ring; Lori M Zeltser
Journal:  J Clin Invest       Date:  2010-07-01       Impact factor: 14.808

3.  Mammary ductal growth is impaired in mice lacking leptin-dependent signal transducer and activator of transcription 3 signaling.

Authors:  Stephanie R Thorn; Sarah L Giesy; Martin G Myers; Yves R Boisclair
Journal:  Endocrinology       Date:  2010-05-25       Impact factor: 4.736

4.  Interleukin-8 Activates Breast Cancer-Associated Adipocytes and Promotes Their Angiogenesis- and Tumorigenesis-Promoting Effects.

Authors:  Huda H Al-Khalaf; Bothaina Al-Harbi; Adher Al-Sayed; Maria Arafah; Asma Tulbah; Abdulaziz Jarman; Falah Al-Mohanna; Abdelilah Aboussekhra
Journal:  Mol Cell Biol       Date:  2019-01-03       Impact factor: 4.272

5.  Obesity and p16INK4A Downregulation Activate Breast Adipocytes and Promote Their Protumorigenicity.

Authors:  Huda H Al-Khalaf; Mrad Amir; Falah Al-Mohanna; Asma Tulbah; Adher Al-Sayed; Abdelilah Aboussekhra
Journal:  Mol Cell Biol       Date:  2017-08-11       Impact factor: 4.272

Review 6.  Three questions about leptin and immunity.

Authors:  Giamila Fantuzzi
Journal:  Brain Behav Immun       Date:  2008-10-25       Impact factor: 7.217

7.  Human IL6 enhances leptin action in mice.

Authors:  M Sadagurski; L Norquay; J Farhang; K D'Aquino; K Copps; M F White
Journal:  Diabetologia       Date:  2009-11-10       Impact factor: 10.122

8.  Changes in insulin sensitivity during leptin replacement therapy in leptin-deficient patients.

Authors:  Gilberto Paz-Filho; Karin Esposito; Barry Hurwitz; Anil Sharma; Chuanhui Dong; Victor Andreev; Tuncay Delibasi; Halil Erol; Alejandro Ayala; Ma-Li Wong; Julio Licinio
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-14       Impact factor: 4.310

Review 9.  Leptin Signaling in the Control of Metabolism and Appetite: Lessons from Animal Models.

Authors:  Alberto A Barrios-Correa; José A Estrada; Irazú Contreras
Journal:  J Mol Neurosci       Date:  2018-10-03       Impact factor: 3.444

Review 10.  Adipokines and the peripheral and neural control of energy balance.

Authors:  Rexford S Ahima; Mitchell A Lazar
Journal:  Mol Endocrinol       Date:  2008-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.